Transcat, Inc.
Transcat, Inc. provides calibration and laboratory instrument services globally. The company operates through two segments: Service and Distribution. The Service segment offers various services, including calibration, repair, inspection, and consulting. It also provides proprietary document and asset management systems for customers. The Distribution segment sells and rents test instruments, offering value-added services like calibration and equipment rental. The company serves highly regulated industries, including life science, aerospace, and energy. Transcat was incorporated in 1964 and is headquartered in Rochester, New York.
Overview
Strengths
- Asset-light, cash-generative model: capital expenditure takes only 4.5% of revenue and free cash flow was positive in each of the last 7 years.
- Consistent growth: revenue has compounded at 11.5% a year over 6 years, rising every year.
Weaknesses
- Eroding returns: ROIC has fallen to 7.9% from a multi-year average of 13.7%, a possible sign of a weakening moat.
- High leverage: net debt is 3.5x EBITDA, against a median of 1.8x for its Specialty Business Services peers.
- Our discounted cash flow target price (16.03 USD) is 84% below the current price.
- Valued at a premium to its Specialty Business Services peers: P/FCF 47.9x vs. a median of 9.2x and EV/EBITDA 27.6x vs. a median of 6.3x.
- Shareholder dilution: the share count has grown by 6.9% a year over the last three years.
- Deteriorating fundamentals over the last year: return on assets down 2.6 points and asset turnover down 4.4%.
Key Financial Data